190 related articles for article (PubMed ID: 8935860)
21. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
22. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
[TBL] [Abstract][Full Text] [Related]
23. [The role of cancer registries in the surveillance, epidemiologic research and disease prevention].
Bouvier AM; Dancourt V; Faivre J
Bull Cancer; 2003 Oct; 90(10):865-71. PubMed ID: 14706915
[TBL] [Abstract][Full Text] [Related]
24. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
25. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000.
Sarkeala T; Anttila A; Forsman H; Luostarinen T; Saarenmaa I; Hakama M
Eur J Cancer; 2004 Sep; 40(14):2116-25. PubMed ID: 15341987
[TBL] [Abstract][Full Text] [Related]
26. [Breast cancer screening in France].
Philip T; Kasparian C; Fagnani F; Moatti JP; Meunier A
Bull Acad Natl Med; 2005 Feb; 189(2):321-36; discussion 336-9. PubMed ID: 16114862
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
28. [Breast cancer: epidemiology, risk factors, screening].
Gairard B; Mathelin C; Schaffer P; Brettes JP
Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
[TBL] [Abstract][Full Text] [Related]
29. [Departmental compilation of histoprognostic data in senology. Apropos of campaign screening in Bouches-du-Rhône].
Jacquemier J; Assada M; Aubert H; Basbous D; Henric A; Jouve MP; Meynard P; Pellegrin E; Pizzi M; Saux MA
Bull Cancer; 1992; 79(10):999-1008. PubMed ID: 1292766
[TBL] [Abstract][Full Text] [Related]
30. [Breast cancer in Loire-Atlantique : situation before the mass screening campaign].
Chouillet AM; Fiche M; Weber J
Rev Epidemiol Sante Publique; 1999 Jun; 47(3):297-8. PubMed ID: 10422123
[No Abstract] [Full Text] [Related]
31. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
[TBL] [Abstract][Full Text] [Related]
32. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of individual breast cancer screening in the Alpes-Maritimes].
Fontas P; Bregeault A; Maestro C; Namer M; Obadia Y; Rotily M
J Radiol; 1996 Sep; 77(9):657-62. PubMed ID: 8944122
[TBL] [Abstract][Full Text] [Related]
34. Geographic association between mammography use and mortality reduction in the US.
Das B; Feuer EJ; Mariotto A
Cancer Causes Control; 2005 Aug; 16(6):691-9. PubMed ID: 16049808
[TBL] [Abstract][Full Text] [Related]
35. The West Midlands breast cancer screening status algorithm - methodology and use as an audit tool.
Lawrence G; Kearins O; O'Sullivan E; Tappenden N; Wallis M; Walton J
J Med Screen; 2005; 12(4):179-84. PubMed ID: 16417694
[TBL] [Abstract][Full Text] [Related]
36. [The general practitioner and screening for cancer of the breast. Study of a sample of 200 general practitioners in the Bas-Rhin].
Schaffer P; Renaud R; Gérard A; Gairard B
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):163-71. PubMed ID: 1583293
[TBL] [Abstract][Full Text] [Related]
37. Modelling the effect of breast cancer screening on related mortality using French data.
Uhry Z; Hédelin G; Colonna M; Asselain B; Arveux P; Exbrayat C; Guldenfelds C; Soler-Michel P; Molinié F; Trétarre B; Rogel A; Courtial I; Danzon A; Guizard AV; Ancelle-Park R; Eilstein D; Duffy S
Cancer Epidemiol; 2011 Jun; 35(3):235-42. PubMed ID: 21159568
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
Viguier J; Nathan Mle Q
Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
[TBL] [Abstract][Full Text] [Related]
39. [Role of cancer registries].
Schaffer P
Bull Acad Natl Med; 1995 May; 179(5):951-62; discussion 962-3. PubMed ID: 7583467
[TBL] [Abstract][Full Text] [Related]
40. [Basic principles of a breast cancer detection program].
Renaud R; Gairard B; Haehnel P; Schaffer P; Reys P
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):565-77. PubMed ID: 3312385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
